ArticleFrontiers in digital health2025
Skin disease diagnosis using decision and feature level fusion of deep features.
Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early skin disease diagnosis is essential and one of the challenging tasks for a dermatologist. Manual diagnosis by healthcare providers is subjective, costly, and may yield inconsistent results. In contrast, automated skin disease detection and classification using traditional machine learning and deep learning approaches have shown promise in addressing this problem. Methods: In this study, we propose a hybrid ensemble framework that integrates both feature-level fusion (FLF) and decision-level fusion (DLF) to leverage complementary strengths for detecting and classifying skin diseases. We employ two convolutional neural network (CNN)-based models, i.e., a modified DenseNet201 and VGG19, along with an attention-based model vision transformer (ViT) to identify and classify skin diseases. In FLF, feature representations from these models are point-wise added and passed through a shared classification head to make the final prediction. In DLF, decisions from each base model are collected, and the majority voting scheme is used to make a final decision. Furthermore, we incorporate a generative adversarial network (GAN)-based approach for offline-based training data augmentation to reduce overfitting and improve performance. Results: Based on different evaluation metrics (i.e., accuracy, precision, recall, and F1-score), our proposed framework demonstrates superior performance on four benchmark datasets: the PH2, HAM10000, ISIC 2018, and ISIC 2019 datasets, with an accuracy of 99.3%/99.2%, 92.7%/96.1%, 86.7%/89.0%, and 94.5%/95.0%, respectively, for FLF/DLF. Discussion: These results demonstrate that while both fusion strategies are effective, DLF slightly outperforms FLF, emphasizing the value of ensemble decision aggregation for robust skin disease classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.